B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

RXRA

MOLECULAR TARGET

retinoid X receptor alpha

UniProt: P19793NCBI Gene: 625653 compounds

RXRA (retinoid X receptor alpha) is targeted by 53 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting RXRA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Dehydroepiandrosterone Sulfate1.956
2methyl 13-(alpha-naphthalene)aminodeisopropyldehydroabietate [Supplementary Concept]1.393
3Sulindac1.393
4Thyroxine1.102
5Progesterone1.102
6Vitamin1.102
7Aldosterone1.102
8Calcitriol1.102
9Dactinomycin1.102
10Domperidone1.102
11Ethylene Chlorohydrin Used as1.102
12Phenol1.102
13Retinaldehyde1.102
14Ribitol1.102
15Sorbic Acid Mold and yeast inhibitor. Used as1.102
16Stavudine1.102
17Sulfanilamide1.102
18Thiabendazole 2-Substituted benzimidazole first introduced in 1962. It is active against1.102
19Thyroxine1.102
20Xylitol1.102
21Arachidonic Acid0.691
22Genistein0.691
23Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as0.691
24Quercetin0.691
25Testosterone0.691
26Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as0.691
27Acetylcysteine0.691
28Adenosine0.691
29Anthraquinones Compounds based on ANTHRACENES which contain two KETONES in0.691
30Chloral Hydrate0.691
31Chloralose0.691
32Cilostazol0.691
33Diflubenzuron0.691
34Dihydrotestosterone0.691
35dimethyl formamide0.691
36Dimethylformamide0.691
37Diuron0.691
38Ethidium0.691
39Ezetimibe0.691
40Flutamide0.691
41Gemfibrozil0.691
42Lutein0.691
43Niclosamide0.691
44Niflumic Acid0.691
45Nitrofurazone0.691
46Oxaprozin0.691
47Piperazine0.691
48Rosuvastatin Calcium0.691
49Rotenone0.691
50Sulfamethazine0.691

Showing top 50 of 53 compounds. Use the BiohacksAI search to explore all RXRA modulators.

About RXRA as a Drug Target

RXRA (retinoid X receptor alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 53 compounds with documented RXRA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

RXRA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.